MAPT and Alzheimer disease: APOE impedes microglial response, blocks Aβ clearance, hastens Aβ aggregation, affects tau pathology and tau-mediated neurodegeneration, and compromises synaptic integrity and plasticity, thereby contributing to the development of AD (Yamazaki et al., 2019).